Die Akanthamöbenkeratitis – ein seltenes und oft spät diagnostiziertes Chamäleon

Zusammenfassung

Der Anteil der Kontaktlinsenträger bei Patienten mit Akanthamöbenkeratitis liegt bei 83 – 93 %. Zur Diagnosestellung einer Akanthamöbeninfektion werden heute – aufgelistet in absteigender Reihenfolge bezüglich Sensitivität und Spezifität – Polymerase-Kettenreaktion (PCR), konfokale Biomikroskopie, In-vitro-Kultivierung und histopathologische Untersuchungen eingesetzt. Das typische Bild der Akanthamöbenkeratitis wird durch pseudodendritiforme Epitheliopathie, Perineuritis, Ringinfiltrat oder multifokale stromale Infiltrate geprägt. Des Weiteren kann eine Limbitis mit Infiltration der Konjunktiva oder eine Uveitis anterior auftreten. Informationen über die Effektivität und Sicherheit der medikamentösen und chirurgischen Therapie konnten bisher nur aus publizierten Fallserien gezogen werden und wurden noch nicht durch randomisierte kontrollierte klinische Studien abgesichert. Wird die Diagnose rechtzeitig gestellt, kann eine Akanthamöbenkeratitis durch dreifache medikamentöse Therapie (Polyhexamid, Propamidinisoethionat, Neomycin) behandelt werden. Die Therapiedauer beträgt jedoch auch bei rechtzeitigem Beginn bis zu einem Jahr. Bei Therapieresistenz kann eine Kryotherapie, Amnionmembrantransplantation, Crosslinkingtherapie oder eine therapeutische Keratoplastik notwendig werden. Die Prognose einer Keratoplastik verbessert sich, wenn mindestens drei Monate lang vor der Operation keine Infektionszeichen mehr bestanden.

Abstract

In 83 – 93 % of the cases of acanthamoeba keratitis the patients are contact lens wearers. Acanthamoeba keratitis is diagnosed – with descending order of sensitivity and specificity – through polymerase chain reaction (PCR), confocal biomicroscopy, in-vitro cultivation and histopathological examination. The typical clinical appearance of acanthamoeba keratitis includes pseudodendritic epitheliopathy, perineuritis, ring infiltrate or multifocal stromal infiltrates and in some cases limbitis with infiltration of the conjunctiva and/or sterile anterior uveitis. Information on reliability and efficacy of the medical/surgical therapy for acanthamoeba keratitis has only been published for case series and It has not been verified through randomised controlled clinical studies so far. By early diagnosis, using triple-topical therapy (polyhexamid, propamidinisoethionat, neomycin) acanthamoeba keratitis often heals appropriately. However, even if diagnosed early, topical therapy should be continued for 1 year. In therapy-resistant cases cryotherapy, amniotic membrane transplantation, cross-linking therapy, and therapeutic keratoplasty are performed. The prognosis of keratoplasty following acanthamoeba keratitis is more favourable when there were no signs of infection at least during the preceding 3 months.

Schlüsselwörter

Akanthamöbenkeratitis - Diagnose - Therapie - Komplikationen - Deutsches Register

Key words

acanthamoeba keratitis - diagnosis - therapy - complications - German Registry

• Literatur

• 1 Meltendorf C, Duncker G. Akanthamöben-Keratitis. Klin Monatsbl Augenheilkd 2011; 228: R29-R43
• 2 Naginton J, Watson PG, Playfair TJ et al. Amoebic infection of the eye. Lancet 1974; 2: 1537-1540
• 3 Jones DB, Visvesvara GS, Robinson NM. Acanthamoeba polyphaga keratitis and Acenthamoeba uveitis associated with fatal meningoencephalitis. Trans Ophthalmol Soc UK 1975; 95: 221-232
• 4 Ku JY, Chan FM, Beckingsale P. Acanthamoeba keratitis cluster: an increase in Acanthamoeba keratitis in Australia. Clin Experiment Ophthalmol 2009; 37: 181-190
• 5 Moore MB, McCulley JP, Newton C et al. Acanthamoeba keratitis. A growing problem in soft and hard contact lens wearers. Ophthalmology 1987; 94: 1654-1661
• 6 Schaumberg DA, Snow KK, Dana MR. The epidemic of Acanthamoeba keratitis: where do we stand?. Cornea 1998; 17: 3-10
• 7 Seal DV. Acanthamoeba keratitis update – incidence, molecular epidemiology and new drugs for treatment. Eye (Lond) 2003; 17: 893-905
• 8 Butler TK, Males JJ, Robinson LP et al. Six-year review of Acanthamoeba keratitis in New South Wales, Australia: 1997–2002. Clin Experiment Ophthalmol 2005; 33: 41-46
• 9 Acharya NR, Lietman TM, Margolis TP. Parasites on the rise: a new epidemic of Acanthamoeba keratitis. Am J Ophthalmol 2007; 144: 292-293
• 10 Dart JK, Saw VP, Kilvington S. Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol 2009; 148: 487-499
• 11 Bacon AS, Frazer DG, Dart JK et al. A review of 72 consecutive cases of Acanthamoeba keratitis, 1984–1992. Eye (Lond) 1993; 7: 719-725
• 12 Carvalho FR, Foronda AS, Mannis MJ et al. Twenty years of Acanthamoeba keratitis. Cornea 2009; 28: 516-519
• 13 McAllum P, Bahar I, Kaiserman I et al. Temporal and seasonal trends in Acanthamoeba keratitis. Cornea 2009; 28: 7-10
• 14 Radford CF, Lehmann OJ, Dart JK. National Acanthamoeba Keratitis Study Group. Acanthamoeba keratitis: multicentre survey in England 1992–1996. Br J Ophthalmol 1998; 82: 1387-1392
• 15 Chew HF, Yildiz EH, Hammersmith KM et al. Clinical outcomes and prognostic factors associated with Acanthamoeba keratitis. Cornea 2011; 30: 435-41
• 16 Watt K, Swarbrick HA. Microbial keratitis in overnight orthokeratology: review of the first 50 cases. Eye Contact Lens 2005; 31: 201-208
• 17 Hammersmith KM. Diagnosis and management of Acanthamoeba keratitis. Curr Opin Ophthalmol 2006; 17: 327-331
• 18 Johnston SP, Sriram R, Qvarnstrom Y et al. Resistance of Acanthamoeba cysts to disinfection in multiple contact lens solutions. J Clin Microbiol 2009; 47: 2040-2045
• 19 Stehr-Green JK, Bailey TM, Visvesvara GS. The epidemiology of Acanthamoeba keratitis in the United States. Am J Ophthalmol 1989; 107: 331-336
• 20 Sharma S, Garg P, Rao GN. Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis. Br J Ophthalmol 2000; 84: 1103-1108
• 21 Weekers PH, Bodelier PL, Wijen JP et al. Effects of grazing by the free-living soil amoebae Acanthamoeba castellanii, Acanthamoeba polyphaga, and Hartmannella vermiformis on various bacteria. Appl Environ Microbiol 1993; 59: 2317-2319
• 22 Gupta S, Das SR. Stock cultures of free-living amebas: effect of temperature on viability and pathogenicity. J Parasitol 1999; 85: 137-139
• 23 De Jonckheere J, van de Voorde H. Differences in destruction of cysts of pathogenic and nonpathogenic Naegleria and Acanthamoeba by chlorine. Appl Environ Microbiol 1976; 31: 294-297
• 24 Khunkitti W, Lloyd D, Furr JR et al. Acanthamoeba castellanii: growth, encystment, excystment and biocide susceptibility. J Infect 1998; 36: 43-48
• 25 Brown TJ, Cursons RT. Pathogenic free-living amebae (PFLA) from frozen swimming areas in Oslo, Norway. Scand J Infect Dis 1977; 9: 237-240
• 26 Aksozek A, McClellan K, Howard K et al. Resistance of Acanthamoeba castellanii cysts to physical, chemical, and radiological conditions. J Parasitol 2002; 88: 621-623
• 27 Mazur T, Hadas E, Iwanicka I. The duration of the cyst stage and the viability and virulence of Acanthamoeba isolates. Trop Med Parasitol 1995; 46: 106-108
• 28 Pussard M, Pons R. Morphologies de la paroi kystique et taxonomie du genre Acanthamoeba (Protozoa, Amoebida). Protistologica 1977; 13: 557-610
• 29 Stothard DR, Hay J, Schroeder-Diedrich JM et al. Fluorescent oligonucleotide probes for clinical and environmental detection of Acanthamoeba and the T4 18S rRNA gene sequence type. J Clin Microbiol 1999; 37: 2687-2693
• 30 Panjwani N. Pathogenesis of Acanthamoeba keratitis. Ocul Surf 2010; 8: 70-79
• 31 Clarke DW, Niederkorn JY. The pathophysiology of Acanthamoeba keratitis. Trends Parasitol 2006; 22: 175-180
• 32 Hadas E, Mazur T. Proteolytic enzymes of pathogenic and non-pathogenic strains of Acanthamoeba spp. Trop Med Parasitol 1993; 44: 197-200
• 33 Moore MB, McCulley JP, Kaufman HE et al. Radial keratoneuritis as a presenting sign in Acanthamoeba keratitis. OPhthalmology 1986; 93: 1310-1315
• 34 Alfawaz A. Radial keratoneuritis as a presenting sign in Acanthamoeba keratitis. Middle East Afr J Ophthalmol 2011; 18: 252-255
• 35 Awwad ST, Petroll WM, McCulley JP et al. Updates in Acanthamoeba keratitis. Eye Contact Lens 2007; 33: 1-8
• 36 Perry HD, Donnenfeld ED, Foulks GN et al. Decreased corneal sensation as an initial feature of Acanthamoeba keratitis. Ophthalmology 1995; 102: 1565-1568
• 37 Seitz B, Heiligenhaus A. „Herpeskeratitis.“ Unterschiedliche Ausprägungsformen erfordern unterschiedliche Therapieansätze. Ophthalmologe 2011; 108: 385-395
• 38 Patel DV, McGhee CN. Acanthamoeba keratitis: a comprehensive photographic reference of common and uncommon signs. Clin Experiment Ophthalmol 2009; 37: 232-238
• 39 Niederkorn JY, Alizadeh H, Leher H et al. The pathogenesis of Acanthamoeba keratitis. Microbes Infect 1999; 1: 437-443
• 40 Holbach LM, Hinzpeter EN, Naumann GOH. Kornea und Sklera. In: Naumann GOH, [Hrsg.] Pathologie des Auges. Heidelberg: Springer; 1997: 596-635
• 41 Papathanassiou M, Gartry D. Sterila corneal ulcer with ring infiltrate and hypopyon after recurrent erosions. Eye 2007; 21: 124-126
• 42 Kremer I, Cohen EJ, Eagle Jr RC et al. Histopathologic evaluation of stromal inflammation in Acanthamoeba keratitis. CLAO J 1994; 20: 45-48
• 43 Clarke DW, Alizadeh H, Niederkorn JY. Failure of Acanthamoeba castellanii to produce intraocular infections. Invest Ophthalmol Vis Sci 2005; 46: 2472-2478
• 44 Herz NL, Matoba AY, Wilhelmus KR. Rapidly progressive cataract and iris atrophy during treatment of Acanthamoeba keratitis. Ophthalmology 2008; 115: 866-869
• 45 Kelley PS, Dossey AP, Patel D et al. Secondary glaucoma associated with advanced acanthamoeba keratitis. Eye Contact Lens 2006; 32: 178-182
• 46 Awwad ST, Heilman M, Hogan RN et al. Severe reactive ischemic posterior segment inflammation in acanthamoeba keratitis: a new potentially blinding syndrome. Ophthalmology 2007; 114: 313-320
• 47 Moshari A, McLean IW, Dodds MT et al. Chorioretinitis after keratitis caused by Acanthamoeba: case report and review of the literature. Ophthalmology 2001; 108: 2232-2236
• 48 Ebrahimi KB, Green WR, Grebe R et al. Acanthamoeba sclerokeratitis. Graefes Arch Clin Exp Ophthalmol 2009; 247: 283-286
• 49 Sun X, Zhang Y, Li R et al. Acanthamoeba keratitis: clinical characteristics and management. Ophthalmology 2006; 113: 412-416
• 50 Claerhout I, Goegebuer A, Van Den Broecke C et al. Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefes Arch Clin Exp Ophthalmol 2004; 242: 648-653
• 51 Reinhard T, Behrens-Baumann W. Anti-infective drug therapy in ophthalmology – part 4: Acanthamoeba keratitis. Klin Monatsbl Augenheilkd 2006; 223: 485-492
• 52 Kitzmann AS, Goins KM, Sutphin JE et al. Keratoplasty for the treatment of acanthamoeba keratitis. Ophthalmology 2009; 116: 864-869
• 53 Duguid IG, Dart JK, Morlet N et al. Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology 1997; 104: 1587-1592
• 54 Lehmann OJ, Green SM, Morlet N et al. Polymerase chain reaction analysis of corneal epithelial and tear samples in the diagnosis of Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 1998; 39: 1261-1265
• 55 Qvarnstrom Y, Visvesvara GS, Sriram R et al. Multiplex real-time PCR assay for simultaneous detection of Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri. J Clin Microbiol 2006; 44: 3589-3595
• 56 Thompson PP, Kowalski RP, Shanks RM et al. Validation of real-time PCR for laboratory diagnosis of Acanthamoeba keratitis. J Clin Microbiol 2008; 46: 3232-3236
• 57 Nakano E, Oliveira M, Portellinha W et al. Confocal microscopy in early diagnosis of Acanthamoeba keratitis. J Refract Surg 2004; 20: 737-740
• 58 Cavanagh HD, Petroll WM, Alizadeh H et al. Clinical and diagnostic use of in vivo confocal microscopy in patients with corneal disease. Ophthalmology 1993; 100: 1444-1454
• 59 Auran JD, Starr MB, Koester CJ et al. In vivo scanning slit confocal microscopy of Acanthamoeba keratitis. A case report. Cornea 1994; 13: 183-185
• 60 Pfister DR, Cameron JD, Krachmer JH et al. Confocal microscopy findings of Acanthamoeba keratitis. Am J Ophthalmol 1996; 121: 119-128
• 61 Mathers WD, Nelson SE, Lane JL et al. Confirmation of confocal microscopy diagnosis of Acanthamoeba keratitis using polymerase chain reaction analysis. Arch Ophthalmol 2000; 118: 178-183
• 62 Parmar DN, Awwad ST, Petroll WM et al. Tandem scanning confocal corneal microscopy in the diagnosis of suspected acanthamoeba keratitis. Ophthalmology 2006; 113: 538-547
• 63 Mathers WD. Acanthamoeba: a difficult pathogen to evaluate and treat. Cornea 2004; 23: 325
• 64 Tu EY, Joslin CE, Sugar J et al. The relative value of confocal microscopy and superficial corneal scrapings in the diagnosis of Acanthamoeba keratitis. Cornea 2008; 27: 764-772
• 65 Zhivov A, Stachs O, Kraak R et al. Cellular laser microscopy of corneal ulcer and infiltrate. Klin Monbl Augenheilkund 2008; 225: 86-90
• 66 Mathers WD, Sutphin JE, Folberg R et al. Outbreak of keratitis presumed to be caused by Acanthamoeba. Am J Ophthalmol 1996; 121: 129-142
• 67 Illingworth CD, Cook SD, Karabatsas CH et al. Acanthamoeba keratitis: risk factors and outcome. Br J Ophthalmol 1995; 79: 1078-1082
• 68 Aspöck H. Grundzüge der Diagnostik. In: Hiepe T, Lucius R, Gottstein B. Allgemeine Parasitologie mit den Grundzügen der Immunologie, Diagnostik und Bekämpfung. Stuttgart: Parey in MVS Medizinverlage; 2006: 477
• 69 Sharma S, Athmanathan S, Atha-Ur-Rasheed M et al. Evaluation of immunoperoxidase staining technique in the diagnosis of Acanthamoeba keratitis. Indian J Ophthalmol 2001; 49: 181-186
• 70 Larkin DF, Kilvington S, Dart JK. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 1992; 99: 185-191
• 71 Kaehn K. Polihexanide: a safe and highly effective biocide. Skin Pharmacol Physiol 2010; 23: 7-16
• 72 Elder MJ, Kilvington S, Dart JK. A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 1994; 35: 1059-1064
• 73 Ficker L, Seal D, Warhurst D et al. Acanthamoeba keratitis – resistance to medical therapy. Eye (Lond) 1990; 4 (06) 835-838
• 74 Wright P, Warhurst D, Jones BR. Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol 1985; 778-782
• 75 McClellan K, Howard K, Niederkorn JY et al. Effect of steroids on Acanthamoeba cysts and trophozoites. Invest Ophthalmol Vis Sci 2001; 42: 2885-2893
• 76 D`Aversa G, Stern GA, Driebe Jr WT. Diagnosis and successful medical treatment of Acanthamoeba keratitis. Arch Ophthalmol 1995; 113: 1120-1123
• 77 Berger ST, Mondino BJ, Hoft RH et al. Successful medical management of Acanthamoeba keratitis. Am J Ophthalmol 1990; 110: 395-403
• 78 Amoils SP, Heney C. Acanthamoeba keratitis with live isolates treated with cryosurgery and fluconazole. Am J Ophthalmol 1999; 127: 718-720
• 79 Tu EY, Joslin CE, Shoff ME. Successful treatment of chronic stromal acanthamoeba keratitis with oral voriconazole monotherapy. Cornea 2010; 29: 1066-1068
• 80 Bang S, Edell E, Eghrari AO et al. Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis. Am J Ophthalmol 2010; 149: 66-69
• 81 Seitz B, Schirra F. Erkrankungen der Hornhaut. In: Erb C, Schlote T, [Hrsg], Medikamentöse Augentherapie. Berlin Heidelberg: Springer; 2010: 138-187
• 82 Oldenburg CE, Acharya NR, Tu EZ et al. Practice patterns and opinions in the treatment of acanthamoeba keratitis. Cornea 2011; 30: 1363-1368
• 83 Lindquist TD. Treatment of Acanthamoeba keratitis. Cornea 1998; 17: 11-16
• 84 Brooks Jr JG, Coster DJ, Badenoch PR. Acanthamoeba keratitis. Resolution after epithelial debridement. Cornea 1994; 13: 186-189
• 85 Holland GN, Donzis PB. Rapid resolution of early Acanthamoeba keratitis after epithelial debridement. Am J Ophthalmol 1987; 104: 87-89
• 86 Ishibashi Y, Matsumoto Y, Kabata T et al. Oral itraconazole and topical miconazole with debridement for Acanthamoeba keratitis. Am J Ophthalmol 1990; 109: 121-126
• 87 Binder PS. Cryotherapy for medically unresponsive Acanthamoeba keratitis. Cornea 1989; 8: 106-114
• 88 Reinhard T, Sundmacher R. Clinical aspects and therapy of Acanthamoeba keratitis. Ophthalmologe 2000; 97: 446-459
• 89 Klüppel M, Reinhard T, Sundmacher R et al. Therapie der fortgeschrittenen Amöbenkeratitis mit Keratoplastik á chaud und adjuvanter Kryoapplikation. Ophthalmologe 1997; 94: 99-103
• 90 Bourcier T, Patteau F, Borderie V et al. Amniotic membrane transplantation for the treatment of severe acanthamoeba keratitis. Can J Ophthalmol 2004; 39: 621-631
• 91 Resch MD, Schlötzer-Schrehardt U, Hofmann-Rummelt C et al. Integration patterns of cryopreserved amniotic membranes into the humen cornea. Ophthalmology 2006; 113: 1927-1935
• 92 Szentmáry N, Goebels S, Bischoff M et al. Photodynamische Therapie (PDT) bei infektiöser Keratitis. Ophthalmologe 2012; 109: 165-170
• 93 Khan YA, Kashiwabuchi RT, Martins SA et al. Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeben keratitis: report of 3 cases. Ophthalmology 2011; 118: 324-331
• 94 Kitzmann AS, Goins KM, Sutphin JE et al. Keratoplasty for treatment of Acanthamoeba keratitis. Ophthalmology 2009; 116: 864-869
• 95 Küchle M, Langenbucher A, Seitz B et al. Nonmechanical excimer laser penetrating keratoplasty for perforated or predescemetal corneal ulcers. Ophthalmology 1999; 106: 2203-2209
• 96 Seitz B, Langenbucher A, Kuss MM et al. Nonmechanical corneal trephination with the excimer laser improves outcome after penetrating keratoplasty. Ophthalmology 1999; 1556-1564
• 97 Szentmáry N, Langenbucher A, Kus MM et al. Elliptical nonmechanical corneal trephination – Intraoperative complications and long-term outcome of 42 consecutive penetrating keratoplasties. Cornea 2007; 26: 414-420
• 98 Hargrave SL, McCulley JP, Husseini Z. Results of a trial of combined propamidine isethionate and neomycin therapy for Acanthamoeba keratitis. Brolene Study Group. . Ophthalmology 1999; 106: 952-957